Ascendis Pharma A/S
ASND
Classifica tra le azioni
#1466
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing... Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 ß/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.
Prezzo delle azioni
$238.30
Ultima sincronizzazione: 2026-10-21
Capitalizzazione di mercato
$14.86B
Variazione (1 giorno)
1.69%
Variazione (1 anno)
17.56%
Paese
DK
Scambia Ascendis Pharma A/S (ASND)
Categoria
Healthcare
Storico del prezzo dell'azione per Ascendis Pharma A/S (ASND)
Prezzo di chiusura più alto: $228.08 il 2026-10-01
Prezzo di chiusura più basso: $19.55 il 2015-01-01
Prezzo di chiusura più basso: $19.55 il 2015-01-01
Storico del prezzo dell'azione di Ascendis Pharma A/S dal 2015 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | 11.08% |
| 2025 | 53.71% |
| 2024 | 15.66% |
| 2023 | -2.60% |
| 2022 | -12.93% |
| 2021 | -20.35% |
| 2020 | 42.79% |
| 2019 | 94.20% |
| 2018 | 63.66% |
| 2017 | 87.65% |
| 2016 | 15.96% |
| 2015 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.07 | -4.31% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
